LATAMBif Registry: February 2021 Report

The Latin American Registry of Percutaneous Coronary Bifurcations continues to develop at a steady pace. 

The aim of this prospective multicenter registry is to assess the reality of percutaneous coronary bifurcation to define its needs and establish effective strategies to perfect the daily clinical practice. 

Bellow you will find data from February 2021, which includes all patients enrolled by the different Latin American centers taking part in the register. 

February data

So far, the registry has included 157 patients of mean age 65.65 (+- 11.35): 86,1% men, and 13,9% women.

Among the risk factors, we have found 82,4% had a history of hypertension, 76,9% dyslipidemia, 12,8% were smokers, 17,6% had type 2 diabetes and 1,6% had type 1 diabetes. In addition, 42,8% had prior PCI, 5,9% prior CABG and 27,3% prior MI.

Of all included patients, 37,4% presented chromic coronary syndrome, 26,7% unstable angina, 17,1% Non-ST acute myocardial infarction (NSTEMI), 11,2% were asymptomatic (silent ischemia) 7,5% ST elevation MI (STEMI).

As regards clinical indications, 55,1% received elective indication, 35,8% urgent indication and 9,1% emergency indication.

83,3% of vascular access was transradial (proximal), 3,2% transradial (distal) and12, 13,4% femoral.

As to the initial strategy, 73,3% was the provisional stent technique and 26,7% the two stent technique.

How to make part of the LATAM Bif Registry?

Write to latambif@gmail.com. You will receive all the information and documentation required for LATAMBif, coordinated by SOLACI Research.

Why take part in LATAM Bif?

  1. The chance to access your own database dedicated to coronary bifurcations, with unified variables for all centers across Latin America. 
  2. Each center will own their data and will be able to analyze outcomes in real time. 
  3. The chance to interact with centers interested in research and publication throughout the region. 
  4. The chance to present at local and international events the outcomes of LATAM Bif Registry.
  5. In case you might need help to develop research projects and/or carry out statistical analysis, you will have the support of SOLACI Research.
  6. SOLACI Research will provide weekly auditing for all data, initial and annual (mandatory followup), for it to be charged correctly. 

Write now to latambif@gmail.com and start participating of LATAM Bif.



Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Fellow’s Corner – Case 2: Acute Myocardial Infarction Due to Simultaneous Occlusion of Two Coronary Arteries

Share your experience. Learn from experts. Grow as an interventional cardiologist. A new edition of the Fellow’s Corner is here, an academic exchange space designed...

V International Course on Cardiovascular Interventionism – SOLACI Scientific Endorsement

The Latin American Society of Interventional Cardiology (SOLACI) proudly grants its scientific endorsement to the V International Course on Cardiovascular Interventionism, an important academic...

Guatemala Sessions 2026 – Young Interventional Cardiologists Contest – Submit Your Case

The call for applications to participate in the Young Interventional Cardiologists Competition at the Guatemala 2026 Regional Sessions is now open. The event will...

Watch Again: Clinical Implications of Structural Heart Interventions — TAVI and MitraClip in Daily Practice

The recording of the webinar “Structural Interventions: TAVI and MitraClip in Daily Practice” is now available on the SOLACI YouTube channel. The activity was...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

Coronary Obstruction During TAVI: A New Volumetric Index to Consider

Coronary obstruction during TAVI is an uncommon but potentially catastrophic complication, particularly in valve-in-valve procedures, in anatomies with small sinuses of Valsalva, low coronary...

EARLY TAVR: Impact of Age on Outcomes of Early TAVR in Asymptomatic Patients

Asymptomatic severe aortic stenosis represents an increasingly common clinical challenge. Although current guidelines recommend intervention once symptoms develop or left ventricular dysfunction occurs, concerns...

Plaque Ruptures in Non-Culprit Arteries: Follow-Up With Intravascular Imaging

Plaque rupture remains one of the most important pathophysiological mechanisms in acute coronary syndromes. However, not all ruptures manifest clinically as ischemia, myocardial infarction,...